ArticleOncotarget2017

Melatonin protects against blood-brain barrier damage by inhibiting the TLR4/ NF-κB signaling pathway after LPS treatment in neonatal rats.

Yingying Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.